US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 0.1367
  • +0.0043+3.25%
Close Apr 26 16:00 ET
  • 0.1368
  • +0.0001+0.07%
Post 16:22 ET
5.93MMarket Cap-273P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Date

Currency: USD

Period

H1 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.20

+62.96%
Analyst Rating

No Data

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--

NLS Pharmaceutics Earnings Reports

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 16 04:05

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 22 05:18

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 21:03

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 7, 2023 05:44

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg